US2022184002A1PendingUtilityA1
Topical dapsone and dapsone/adapalene compositions and methods for use thereof
Est. expiryNov 20, 2032(~6.4 yrs left)· nominal 20-yr term from priority
A61K 31/192A61P 17/00A61K 47/32A61K 9/0014A61K 47/10A61K 47/14A61P 29/00Y02A50/30A61K 31/136A61P 17/08A61K 31/145A61P 17/04A61K 47/183A61P 43/00A61P 17/10A61P 37/08A61P 17/02A61P 17/12A61K 47/34
78
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
Dapsone and dapsone/adapalene compositions can be useful for treating a variety of dermatological conditions. The compositions of this disclosure include dapsone and/or adapalene in a polymeric viscosity builder. Subject compositions can be adjusted to optimize the dermal delivery profile of dapsone to effectively treat dermatological conditions and improve the efficiency of pharmaceutical products applied to the skin. Use of the polymeric viscosity builder provides compositions with increased concentrations of diethylene glycol monoethyl ether relative to compositions without the polymeric viscosity builder.
Claims
exact text as granted — not AI-modified1 - 12 . (canceled)
13 . A method of treating acne vulagaris comprising administering to a subject in need thereof a therapeutically effective amount of topical pharmaceutical composition comprising:
7.5% w/w dapsone; about 30% w/w diethylene glycol monoethyl ether; about 4% w/w of a polymeric viscosity builder comprising acrylamide/sodium acryloyldimethyl taurate copolymer; 0.2% w/w methyl paraben; and water; wherein the dapsone is the sole active agent for the treatment of acne in the composition.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.